| 07:00 - 08:15 | 202 | CC3 Lung cancer: personalised treatment and palliative care | Challenging clinical cases |
| 07:00 - 08:15 | 205 | CC4 Tuberculosis | Challenging clinical cases |
| 07:00 - 08:15 | 206 | CC5 Pulmonary vasculitis: the great chameleon | Challenging clinical cases |
| 08:30 - 10:30 | 210 | Paediatric Grand Round | Grand round |
| 08:30 - 10:30 | 211 | State of the art session: Thoracic oncology | Symposium |
| 08:30 - 10:30 | 212 | Therapeutic breakthroughs Year in Review | Year in review |
| 08:30 - 10:30 | 213 | New trends in the management of difficult-to-wean patients | Symposium |
| 08:30 - 10:30 | 214 | Sleep apnoea: is it time for new therapies? | Symposium |
| 08:30 - 10:30 | 215 | Rare lung diseases | Symposium |
| 08:30 - 10:30 | 216 | New modalities in asthma treatment | Oral Presentation |
| 08:30 - 10:30 | 217 | Pulmonary embolism: what we need to know | Hot topics |
| 08:30 - 10:30 | 218 | Cross-talk in the lung microenvironment: implications for chronic lung disease | Symposium |
| 08:30 - 10:30 | 219 | COPD and chronic respiratory disease: from misclassification to radiological findings | Oral Presentation |
| 08:30 - 10:30 | 220 | Novel drug targets for asthma and COPD | Oral Presentation |
| 08:30 - 10:30 | 221 | Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches | Oral Presentation |
| 08:30 - 10:30 | 222 | New developments in tuberculosis | Oral Presentation |
| 08:30 - 10:30 | 223 | Pleural diseases and pneumonia: what's new ? | Poster Discussion |
| 08:30 - 10:30 | 224 | Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach | Oral Presentation |
| 08:30 - 10:30 | 225 | Integrating pharmacological and non-pharmacological management in COPD: are we there yet? | Poster Discussion |
| 08:30 - 10:30 | 226 | Clinical determinants and biomarkers of COPD | Poster Discussion |
| 08:30 - 10:30 | 227 | Improving the outcomes of community-acquired pneumonia | Poster Discussion |
| 08:30 - 10:30 | 228 | Let’s interact and discuss the hot topics in pulmonary rehabilitation | Poster Discussion |
| 08:30 - 10:30 | 229 | The many facets of respiratory nursing | Poster Discussion |
| 10:45 - 12:45 | 237 | Clinical Year in Review | Year in review |
| 10:45 - 12:45 | 238 | State of the art session: Respiratory infections | Symposium |
| 10:45 - 12:45 | 239 | Infectious agents and childhood asthma | Symposium |
| 10:45 - 12:45 | 240 | Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose | Hot topics |
| 10:45 - 12:45 | 241 | Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure | Symposium |
| 10:45 - 12:45 | 242 | Respiratory medicine meets hematology | Symposium |
| 10:45 - 12:45 | 243 | Intercellular communication in tissue remodelling | Oral Presentation |
| 10:45 - 12:45 | 244 | COPD: from LABA/ICS to LABA/LAMA/ICS | Oral Presentation |
| 10:45 - 12:45 | 245 | Cell-matrix interactions in lung disease and regeneration | Symposium |
| 10:45 - 12:45 | 246 | New predictors of morbidity and mortality in COPD | Oral Presentation |
| 10:45 - 12:45 | 247 | Respiratory muscles and lung function: from healthy subjects to patients | Oral Presentation |
| 10:45 - 12:45 | 248 | Granulomatous disorders: epidemiology, genotype and phenotype | Oral Presentation |
| 10:45 - 12:45 | 249 | Interventional pulmonology highlights in 2018: latest innovations | Oral Presentation |
| 10:45 - 12:45 | 250 | New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases | Poster Discussion |
| 10:45 - 12:45 | 251 | Multiomics studies in epidemiology: what can they tell us? | Oral Presentation |
| 10:45 - 12:45 | 252 | The world of idiopathic pulmonary fibrosis (IPF): global registries | Poster Discussion |
| 10:45 - 12:45 | 253 | Lung cancer: personalised medicine | Poster Discussion |
| 10:45 - 12:45 | 254 | New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children | Poster Discussion |
| 10:45 - 12:45 | 255 | New diagnostic tools for sleep and breathing and healthcare provision options | Poster Discussion |
| 10:45 - 12:45 | 256 | Respiratory epidemiology: from COPD to factors that associate with lung function and infections | Poster Discussion |
| 12:50 - 14:40 | 262 | Critically ill patients: prognostic factors and biomarkers | Thematic Poster |
| 12:50 - 14:40 | 263 | Preclinical and clinical studies of critical illness | Thematic Poster |
| 12:50 - 14:40 | 264 | Muscles and diaphragm, and quality improvement | Thematic Poster |
| 12:50 - 14:40 | 265 | Non-invasive ventilation for acute respiratory failure | Thematic Poster |
| 12:50 - 14:40 | 266 | Non-invasive ventilation in chronic respiratory failure | Thematic Poster |
| 12:50 - 14:40 | 267 | New tools for managing respiratory failure | Thematic Poster |
| 12:50 - 14:40 | 268 | New methods and concepts in tests of lung and respiratory muscle function | Thematic Poster |
| 12:50 - 14:40 | 269 | The value of lung function testing in various pathophysiological conditions | Thematic Poster |
| 12:50 - 14:40 | 270 | Cardiopulmonary exercise testing in COPD and cardiovascular diseases | Thematic Poster |
| 12:50 - 14:40 | 271 | New methods and concepts in exercise testing | Thematic Poster |
| 12:50 - 14:40 | 272 | From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) | Thematic Poster |
| 12:50 - 14:40 | 273 | Diagnostics including questionnaires | Thematic Poster |
| 12:50 - 14:40 | 274 | Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality | Thematic Poster |
| 12:50 - 14:40 | 275 | Obesity: comorbidities | Thematic Poster |
| 12:50 - 14:40 | 276 | Pleural effusions, infections and tumours | Thematic Poster |
| 12:50 - 14:40 | 277 | Moving lung transplantation forward | Thematic Poster |
| 12:50 - 14:40 | 278 | Predicting the future: biomarkers of respiratory infection | Thematic Poster |
| 12:50 - 14:40 | 279 | Pneumonia: from the community to the intensive care unit | Thematic Poster |
| 12:50 - 14:40 | 280 | Mechanisms of respiratory infection | Thematic Poster |
| 12:50 - 14:40 | 281 | Improving the quality of life of patients with bronchiectasis | Thematic Poster |
| 12:50 - 14:40 | 282 | Challenges in tuberculosis care | Thematic Poster |
| 12:50 - 14:40 | 283 | Tuberculosis comorbidities | Thematic Poster |
| 12:50 - 14:40 | 284 | Groups who are susceptible to tuberculosis: children, pregnant women and elderly people | Thematic Poster |
| 12:50 - 14:40 | 285 | Pulmonary tuberculosis: long term complications, rehabilitation and challenges | Thematic Poster |
| 12:50 - 14:40 | 286 | Lung cancer: new tools for diagnosis and patient assessment | Thematic Poster |
| 12:50 - 14:40 | 287 | Lung cancer: novel prognostic markers and scores | Thematic Poster |
| 12:50 - 14:40 | 288 | Lung cancer: modern therapies and beyond | Thematic Poster |
| 12:50 - 14:40 | 289 | Lung cancer: risk factors, supportive measures and quality improvement | Thematic Poster |
| 12:50 - 14:40 | 290 | Lung cancer: from the bench to the bedside | Thematic Poster |
| 12:50 - 14:40 | 291 | Mesothelioma and pleural malignancy: investigations and management | Thematic Poster |
| 12:50 - 14:40 | 292 | Clinical management of pleural malignancies, including mesothelioma | Thematic Poster |
| 12:50 - 14:40 | 293 | Consequences of idiopathic interstitial pneumonias | Thematic Poster |
| 12:50 - 14:40 | 294 | News on the diagnosis of idiopathic interstitial pneumonia | Thematic Poster |
| 12:50 - 14:40 | 295 | Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) | Thematic Poster |
| 12:50 - 14:40 | 296 | CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers | Thematic Poster |
| 12:50 - 14:40 | 297 | Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment | Thematic Poster |
| 12:50 - 14:40 | 298 | Granulomatous disorders: heterogeneous diseases with variable management | Thematic Poster |
| 12:50 - 14:40 | 299 | Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) | Thematic Poster |
| 12:50 - 14:40 | 300 | Pulmonary hypertension: therapy | Thematic Poster |
| 12:50 - 14:40 | 301 | Experimental research in pulmonary hypertension | Thematic Poster |
| 12:50 - 14:40 | 302 | Clinical aspects of pulmonary hypertension | Thematic Poster |
| 12:50 - 14:40 | 303 | Pulmonary hypertension in lung diseases and the role of the right ventricle | Thematic Poster |
| 12:50 - 14:40 | 304 | Diagnosis, prognostication and treatment of pulmonary embolism | Thematic Poster |
| 12:50 - 14:40 | 305 | Medical education via the web and the internet | Thematic Poster |
| 12:50 - 14:40 | 306 | COPD, asthma and tuberculosis: benefits related to therapy costs | Thematic Poster |
| 13:00 - 14:30 | 307 | New biologics for asthma: which patients, which agents, which results, at what cost? | Lunchtime session |
| 13:00 - 14:15 | 314 | Paediatric Respiratory Diseases | Lungs on fire |
| 13:00 - 14:00 | 315 | ME7 Monitoring of home mechanical ventilation in neuromuscular disorders | Meet the expert |
| 13:00 - 14:30 | 316 | PF Occupational lung disease – professional and patient perspectives | Patient forum |
| 13:00 - 14:00 | 317 | ME8 Diagnosing bronchiectasis and cystic fibrosis | Meet the expert |
| 13:00 - 14:00 | 319 | ME5 Lung cancer screening | Meet the expert |
| 14:45 - 16:45 | 333 | Chronic pulmonary aspergillosis: from guidelines to real-life implementation | Hot topics |
| 14:45 - 16:45 | 334 | Imaging chronic lung diseases: moving from structure to function | Symposium |
| 14:45 - 16:45 | 335 | Idiopathic pulmonary fibrosis diagnosis: new guidelines | Guidelines session |
| 14:45 - 16:45 | 336 | Advances in community-acquired pneumonia management | Symposium |
| 14:45 - 16:45 | 337 | Roles of innate lymphoid cells in asthma | Hot topics |
| 14:45 - 16:45 | 338 | Microbiomes in respiratory disease | Symposium |
| 14:45 - 16:45 | 339 | New methods for diagnosing and treating lung diseases | Oral Presentation |
| 14:45 - 16:45 | 340 | Molecular mechanisms and treatment of pulmonary hypertension | Oral Presentation |
| 14:45 - 16:45 | 341 | The best of the European Respiratory Journal in 2018 | Symposium |
| 14:45 - 16:45 | 342 | Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia | Oral Presentation |
| 14:45 - 16:45 | 343 | Ventilation and lung imaging in critically ill patients | Oral Presentation |
| 14:45 - 16:45 | 344 | Lung cancer: new aspects in diagnosis and management | Oral Presentation |
| 14:45 - 16:45 | 345 | Recent insights in childhood asthma and wheezing | Oral Presentation |
| 14:45 - 16:45 | 346 | Pulmonary hypertension: right ventricle function, haemodynamics and exercise | Poster Discussion |
| 14:45 - 16:45 | 347 | Lung transplant science: from primary graft to chronic allograft dysfunction | Oral Presentation |
| 14:45 - 16:45 | 348 | What’s new in lung function and exercise assessment in COPD? | Poster Discussion |
| 14:45 - 16:45 | 349 | Exercise is medicine: testing and treating patients with some effort | Poster Discussion |
| 14:45 - 16:45 | 350 | Cryobiopsy in interstitial lung disease (ILD) | Poster Discussion |
| 14:45 - 16:45 | 351 | Innovations in equipment and their application | Poster Discussion |
| 14:45 - 16:45 | 352 | Latest developments in cystic fibrosis | Poster Discussion |